Anastrozole 01
Anastrozole Tablet
Product Images NDC 51991-620
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 51991-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Anastrozole 02
This appears to be a graph or table presenting data on disease-free survival over a period of time for patients receiving either a treatment of anastrozole or tamoxifen. The data is presented for both treatments in a table with the number of patients at risk over time.*
Anastrozole 03
Anastrozole 04
This is a chart showing the proportion of events free over time for patients randomized to receive either anastrozole or tamoxifen. The horizontal axis shows the time to event in months, while the vertical axis shows the proportion of patients remaining event-free. The number of patients at risk is also shown at various time points. The chart was created using Kaplan-Meier curves. The vertical axis has been truncated to improve clarity.*
Anastrozole 05
Anastrozole 06
This appears to be a graph or chart showing the time to progression in months for randomized treatment with anastrozole and tamoxifen, but without further context or labels it is not possible to determine the specific details or implications of the data.*
Anastrozole 07
This appears to be a graph or chart that shows the progress of a certain treatment (Anastrozole vs Tamoxifen) over a period of months. The x-axis shows the time in months, while the y-axis is labeled as "Proportion not progressing". The numbers on the y-axis range from 0.0 to 1.0. There is an "AT RISK" line that shows the number of participants still in the study at each time point. Without additional context, it is difficult to draw further conclusions.*
Anastrozole 08
Each tablet of this medication contains 1 mg of anastrozole USP, and it is distributed by a company named USUAL DOSAGE. The recommended dosage and additional information can be found in the accompanying Prescribing Information. The medication should be kept out of the reach of children and stored at a controlled room temperature of 20-25°C (68-77°F). The GTIN and NDC codes are 00351991620334 and 51991-620-33 respectively. The lot number of this particular medication is 123456.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
